Related Experiment Video
Updated: Oct 3, 2025
09:05
Pooled CRISPR-Based Genetic Screens in Mammalian Cells
Published on: September 4, 2019
22.3K
Considerations and practical implications of performing a phenotypic CRISPR/Cas survival screen
Ator Ashoti1, Francesco Limone2,3, Melissa van Kranenburg1
1Hubrecht Institute, Developmental Biology and Stem Cell Research, Utrecht, The Netherlands.
Plos One
|February 17, 2022
Summary
This study used CRISPR/Cas9 screens to find ways to combat DUX4 toxicity, a cause of facioscapulohumeral muscular dystrophy (FSHD). Results suggest targeting DUX4 directly is key for treating FSHD.
Area of Science:
- Genetics
- Molecular Biology
- Neuroscience
Background:
- Facioscapulohumeral muscular dystrophy (FSHD) is a complex muscle disorder caused by DUX4 misexpression.
- Current treatments for FSHD are limited, highlighting the need for new therapeutic strategies.
- CRISPR-Cas9 technology offers a powerful tool for genetic screening and identifying therapeutic targets.
Purpose of the Study:
- To perform a genome-wide CRISPR/Cas9 phenotypic rescue screen to identify modulators of DUX4-induced cytotoxicity.
- To investigate potential therapeutic targets for facioscapulohumeral muscular dystrophy (FSHD).
- To understand the genetic basis of DUX4 toxicity.
Main Methods:
- Genome-wide CRISPR/Cas9 phenotypic rescue screen.
- Analysis of DUX4 cytotoxicity.
- Identification of genetic modulators of DUX4 toxicity.
Main Results:
- The screen identified DUX4 itself as the primary modulator of its own cytotoxicity.
- No other key effectors significantly modulated DUX4 cytotoxicity.
- Unexpected genomic events impacted data interpretation, offering insights for future screens.
Conclusions:
- Direct modulation of DUX4 is a promising therapeutic strategy for FSHD.
- Future CRISPR/Cas9 phenotypic survival screens should consider potential genomic event impacts.
- This study provides crucial considerations for designing effective genetic screens in disease research.
